← Leaderboards
Lisa A Kosmiski
University Of Colorado Denver
$3,557,583
Attributed
$3,557,583
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,557,583 · 14
By mechanism
R01$2,036,382 · 2
M01$1,002,415 · 11
K23$518,786 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Brent E Palmer$8,372,659
- Bryan R Haugen$9,253,787
- Zhenqi Liu$10,685,731
- Thomas B. Campbell$27,628,296
- Ryan J. Mays$717,157
Others in their field
Top investigators on “Adipose Tissue”
- Philipp E Scherer · Ut Southwestern Medical Center$35,623,350
- Michael D. Jensen · Mayo Clinic Coll Of Medicine, Rochester$25,247,651
- C Ronald Kahn · Joslin Diabetes Center$24,965,457
- Laura E. Nagy · Case Western Reserve University$24,173,122
- Hei Sook Sul · University Of California Berkeley$23,973,403
- Ziad Nahas · Medical University Of South Carolina$22,722,368
Research focus
Adipose TissueHiv InfectionsHypertriglyceridemiaBody CompositionLipodystrophyHuman SubjectClinical ResearchComputed Axial TomographyInsulin Sensitivity /ResistanceFatty Acid Glycerol EstersAids TherapyProtease InhibitorDrug Adverse EffectHuman Therapy EvaluationObesityMetabolicLeadGene ExpressionLipid MetabolismGrantInstitutionAtherosclerosisCaloriesInsulin Resistance
Grant awards (27)
Energy Expenditure in HIV Lipodystrophy$267,488
R01 · FY2012 · DK · contact PI
Energy Expenditure in HIV Lipodystrophy$267,488
R01 · FY2011 · DK · contact PI
Energy Expenditure in HIV Lipodystrophy$298,089
R01 · FY2010 · DK · contact PI
Energy Expenditure in HIV Lipodystrophy$301,152
R01 · FY2009 · DK · contact PI
PSTPRNDIAL THRMOGNESIS&ENRGTIC CONSEQNCES OF OVRFEED IN PTS W/HIV LIPODYSTROPHY$39,013
M01 · FY2008 · RR · contact PI
FRAM 2: FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$13,898
M01 · FY2008 · RR · contact PI
ACTG A5229 (VS 10):TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY$488
M01 · FY2008 · RR · contact PI
PSTPRNDIAL THRMOGNESIS&ENRGTIC CONSEQNCES OF OVRFEED IN PTS W/HIV LIPODYSTROPHY$197,726
M01 · FY2007 · RR · contact PI
FRAM 2: FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$70,440
M01 · FY2007 · RR · contact PI
ACTG A5229 (VS 10):TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY$2,473
M01 · FY2007 · RR · contact PI
THE EFFECTS OF CALORIC RESTRICTION ON THE HYPERMETABOLISM OF HIV LIPODYSTROPHY$168,178
M01 · FY2006 · RR · contact PI
PSTPRNDIAL THRMOGNESIS&ENRGTIC CONSEQNCES OF OVRFEED IN PTS W/HIV LIPODYSTROPHY$19,194
M01 · FY2006 · RR · contact PI
FRAM 2: FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$13,710
M01 · FY2006 · RR · contact PI
The effects of HIV-1 proteins on adipocyte biology$355,407
R01 · FY2005 · DK
THE EFFECTS OF CALORIC RESTRICTION ON THE HYPERMETABOLISM OF HIV LIPODYSTROPHY$63,589
M01 · FY2005 · RR
The effects of HIV-1 proteins on adipocyte biology$284,145
R01 · FY2004 · DK
Mentored Patient-Oriented Research Career Development Aw$99,119
K23 · FY2004 · RR
The effects of HIV-1 proteins on adipocyte biology$262,613
R01 · FY2003 · DK
Mentored Patient-Oriented Research Career Development Aw$105,071
K23 · FY2003 · RR
HIV PROTEASE INHIBITORS, BODY FAT DISTRIBUTION /METABOLIC DISTURBANCE$190,747
M01 · FY2002 · RR
Mentored Patient-Oriented Research Career Development Aw$101,740
K23 · FY2002 · RR
HIV PROTEASE INHIBITORS, BODY FAT DISTRIBUTION /METABOLIC DISTURBANCE$190,747
M01 · FY2001 · RR
Mentored Patient-Oriented Research Career Development Aw$107,988
K23 · FY2001 · RR
HIV PROTEASE INHIBITORS, BODY FAT DISTRIBUTION /METABOLIC DISTURBANCE$0
M01 · FY2001 · RR
Mentored Patient-Oriented Research Career Development Aw$104,868
K23 · FY2000 · RR
HIV PROTEASE INHIBITORS, BODY FAT DISTRIBUTION /METABOLIC DISTURBANCE$32,212
M01 · FY2000 · RR
HIV PROTEASE INHIBITORS, BODY FAT DISTRIBUTION /METABOLIC DISTURBANCE$0
M01 · FY2000 · RR